Latest Articles

Publication Date
Ananda Developments hails publication of article in TIPS scientific journal - Proactive Investors UK

Ananda Developments hails publication of article in TIPS scientific journal Proactive Investors UK

Published: Nov. 25, 2024, 3:28 p.m.
Ananda Developments hails publication of article in TIPS scientific journal - Proactive Investors USA

Ananda Developments hails publication of article in TIPS scientific journal Proactive Investors USA

Published: Nov. 25, 2024, 3:28 p.m.
Ananda Developments hails publication of article in TIPS scientific journal - Proactive financial news

Ananda Developments hails publication of article in TIPS scientific journal Proactive financial news

Published: Nov. 25, 2024, 3:28 p.m.
Ananda Developments interims chart a period of significant progress - Proactive Investors UK

Ananda Developments interims chart a period of significant progress Proactive Investors UK

Published: Oct. 30, 2024, 7:37 a.m.
Ananda Developments interims chart a period of significant progress - Proactive Investors USA

Ananda Developments interims chart a period of significant progress Proactive Investors USA

Published: Oct. 30, 2024, 7:37 a.m.
IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors - StreetInsider.com

IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors StreetInsider.com

Published: Oct. 29, 2024, 10:11 a.m.
Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 - The Manila Times

Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 The Manila Times

Published: Oct. 25, 2024, 12:29 p.m.
Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 - StockTitan

Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 StockTitan

Published: Oct. 25, 2024, noon
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times

Published: Oct. 23, 2024, 10:06 a.m.
Macrophage reprogramming: new frontier in endometriosis - Drug Discovery & Development

Macrophage reprogramming: new frontier in endometriosis Drug Discovery & Development

Published: Oct. 16, 2024, 10:52 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!